Boston Family Office’s Labcorp LH Stock Holding History

Boston Family Office’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$241K	Buy	903 +53	+6%	+$14.4K	0.02%	292
2025 Q4	$213K	Hold	850	–	–	0.01%	302
2025 Q3	$244K	Hold	850	–	–	0.02%	271
2025 Q2	$223K	Buy	+850	New	+$207K	0.01%	272
2016 Q2	–	Sell	-3,376	Closed	-$340K	–	248
2016 Q1	$340K	Sell	3,376 -5,825	-63%	-$558K	0.04%	204
2015 Q4	$977K	Sell	9,201 -70	-0.8%	-$7.22K	0.13%	141
2015 Q3	$864K	Buy	9,271 +58	+0.6%	+$6K	0.12%	148
2015 Q2	$959K	Buy	9,213 +1,664	+22%	+$173K	0.12%	150
2015 Q1	$818K	Buy	+7,549	New	+$776K	0.1%	165

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Family Office's LH Position: Q1 2026 in Review

Boston Family Office increased its Labcorp (LH) stake by 6.2% in Q1 2026, buying an estimated $14.4K and bringing the position to 903 shares worth $241K. The position accounts for 0.02% of the portfolio, ranked #292.

Boston Family Office first reported a position in LH in Q1 2015 and has held it in 9 quarters since. The position peaked at $977K in Q4 2015. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Boston Family Office held 903 shares of Labcorp worth $241K as of Q1 2026.
Boston Family Office bought 53 Labcorp shares in Q1 2026, an estimated $14.4K.
Labcorp made up 0.02% of Boston Family Office's portfolio in Q1 2026, its #292 holding.
Boston Family Office first reported a position in Labcorp in Q1 2015 and has held it in 9 quarters since.
Boston Family Office's Labcorp position peaked at $977K in Q4 2015.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.